secwatch.observer — SEC 8-K summary
======================================

Issuer:     MAIA Biotechnology, Inc. (MAIA)
CIK:        0001878313
Form:       8-K
Filed at:   2025-10-14T23:59:59+00:00
Accession:  0001493152-25-017948
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

MAIA Biotechnology announces $736,600 private placement of common stock and warrants
--------------------------------------------------------------------------------

- Private placement of 603,769 shares at $1.22 per share with warrants to purchase 603,769 shares at $1.52.
- Gross proceeds ~$736,600; warrants exercisable after six months, three-year term.
- Proceeds to fund Step 1 of Part C of Phase II trial THIO-101 for NSCLC and for working capital.
- Closing expected October 15, 2025; securities issued as restricted, no registration rights.
- Offering exempt under Section 4(a)(2)/Reg D; shares and underlying not registered.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1878313/000149315225017948/0001493152-25-017948-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1878313/000149315225017948/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-017948

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer